KCP
MDLN

Kera Capital Partners’s Medline Inc MDLN Stock Holding History

Kera Capital Partners’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.96M Buy
89,021
+3,379
+4% +$149K 0.49% 43
2025
Q4 		$3.79M Buy
+85,642
New +$3.62M 0.47% 45

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Kera Capital Partners's MDLN Position: Q1 2026 in Review

Kera Capital Partners increased its Medline Inc (MDLN) stake by 3.9% in Q1 2026, buying an estimated $149K and bringing the position to 89,021 shares worth $3.96M. The position accounts for 0.49% of the portfolio, ranked #43.

Kera Capital Partners first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Kera Capital Partners held 89,021 shares of Medline Inc worth $3.96M as of Q1 2026.
  • Kera Capital Partners bought 3,379 Medline Inc shares in Q1 2026, an estimated $149K.
  • Medline Inc made up 0.49% of Kera Capital Partners's portfolio in Q1 2026, its #43 holding.
  • Kera Capital Partners first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Kera Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.